It’s Worth A Gamble To Have A Position In Personalis Inc (NASDAQ: PSNL) At $4.89.

Personalis Inc (NASDAQ:PSNL)’s traded shares stood at 0.52 million during the last session, with the company’s beta value hitting 1.75. At the close of trading, the stock’s price was $4.89, to imply an increase of 2.30% or $0.11 in intraday trading. The PSNL share’s 52-week high remains $7.20, putting it -47.24% down since that peak but still an impressive 77.1% since price per share fell to its 52-week low of $1.12. The company has a valuation of $347.29M, with an average of 0.99 million shares in intraday trading volume over the past 10 days and average of 989.19K shares over the past 3 months.

Analysts have given a consensus recommendation of Hold for Personalis Inc (PSNL), translating to a mean rating of 1.33. Of 13 analyst(s) looking at the stock, 0 analyst(s) give PSNL a Sell rating. 0 of those analysts rate the stock as Overweight while 7 advise Hold as 6 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.28.

Personalis Inc (NASDAQ:PSNL) trade information

After registering a 2.30% upside in the last session, Personalis Inc (PSNL) has traded red over the past five days. The 5-day price performance for the stock is -12.52%, and 31.81% over 30 days. With these gigs, the year-to-date price performance is -15.40%. Short interest in Personalis Inc (NASDAQ:PSNL) saw shorts transact 3.31 million shares and set a 2.57 days time to cover.

The extremes give us $5.5 and $9 for target low and target high price respectively. As such, PSNL has been trading -84.05% off suggested target high and -12.47% from its likely low.

Personalis Inc (PSNL) estimates and forecasts

Looking at statistics comparing Personalis Inc share performance against respective industry, we note that the company has outperformed competitors. Personalis Inc (PSNL) shares are 99.59% up over the last 6 months, with its year-to-date growth rate higher than industry average at 36.87% against 28.10%. The rating firms project that company’s revenue will grow 13.50% compared to the previous financial year.

Revenue forecast for the current quarter as set by 5 analysts is 15.53M. Meanwhile, for the current quarter, a total of 2 analyst(s) estimate revenue growth to 16.23M.Earnings reports from the last fiscal year show that sales brought in 19.77M and 19.52M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -21.42% before dropping -16.88% in the following quarter.

PSNL Dividends

Personalis Inc has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Personalis Inc (NASDAQ:PSNL)’s Major holders

Personalis Inc insiders hold 32.67% of total outstanding shares, with institutional holders owning 44.37% of the shares at 65.89% float percentage. In total, 44.37% institutions holds shares in the company, led by ARK INVESTMENT MANAGEMENT LLC. As of 2024-06-30, the company held over 6.36 million shares (or 12.5534% of shares), all amounting to roughly $7.44 million.

The next major institution holding the largest number of shares is BLACKROCK INC. with 3.29 million shares, or about 6.4961% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $3.85 million.

We also have ARK ETF Tr-ARK Genomic Revolution ETF and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Personalis Inc (PSNL) shares. Going by data provided on Nov 30, 2024 , ARK ETF Tr-ARK Genomic Revolution ETF holds roughly 6.8 shares. This is just over 9.63% of the total shares, with a market valuation of $33.27 million. Data from the same date shows that the other fund manager holds a little less at 1.21, or 1.72% of the shares, all valued at about 5.94 million.